The Latest Breaking News from AstraZeneca

AstraZeneca’s Pascal Soriot and Rolls Royce’s Tufan Erginbilgic were among the highest-paid FTSE 100 CEOs, but what they make still trails behind the average pay of S&P 500 CEOs.

Bosses of UK’s biggest companies are now paid 120 times more than average full-time worker in some instances

The annual conference of the American Society of Clinical Oncology is always the biggest event-making cancer conference. And this year, the attention-grabber was AstraZeneca, as its lung and breast cancer drugs significantly slowed the spread of disease in two trials, potentially establishing the medicines as the new standard of care…

The share price recovery has been partly driven by the surge in wholesale energy prices, which is beyond his control

Women with HER2-low incurable secondary disease in Scotland currently have access, while others across the UK do not

The former pharma laggard is in a race with Shell to be the first FTSE 100 stock to be valued at £200bn

Higher-than expected UK inflation figures disappointed the City today, with shares falling as the 2.3% Consumer Price Index reading dashed hopes of a June interest rate cut.

UK’s biggest drugmaker says it plans to launch 20 major new medicines before the end of the decade

The growth will be fuelled by 20 new drugs that are set to launch this decade